Asymmetry Global Healthcare

Asymmetry® Global Healthcare is a global healthcare sector model investment portfolio applying a systematic quantitative investment program to a global universe of healthcare stocks with the objective of an asymmetric risk/reward profile. Asymmetry® Global Healthcare pursues its objective of positive asymmetry by applying an asymmetric trading system designed for an asymmetric payoff. Asymmetry® Global Healthcare model is available to institutional investors and has a performance history starting in 2002.

Asymmetry Global Healthcare

Why Asymmetry® Global Healthcare?

1. Tactical exposure to pharmaceutical, biotechnology, and medical device companies when they offer a higher probability of asymmetric payoff and an asymmetric risk/reward.

2. Targeted tactical access to healthcare stocks from around the world.

3. Use to express a global sector allocation or view, but with active risk management.

 

ASYMMETRY® Global Sector Portfolios 

 

ASYMMETRY® Global Healthcare Sector

ASYMMETRY® Global Technology Sector

ASYMMETRY® Global Utilities Sector

ASYMMETRY® Global Financials Sector

ASYMMETRY® Global Real Estate REIT Sector

ASYMMETRY® Global Materials Sector

ASYMMETRY® Global Consumer Staples Sector

ASYMMETRY® Global Consumer Discretionary Sector

ASYMMETRY® Global Energy Sector

ASYMMETRY® Global Industrials Sector

 

ASYMMETRY® U. S. Sector Portfolios 

 

ASYMMETRY® U.S. Healthcare Sector

ASYMMETRY® U.S. Technology Sector

ASYMMETRY® U.S. Utilities Sector

ASYMMETRY® U.S. Financials Sector

ASYMMETRY® U.S. Real Estate REIT Sector

ASYMMETRY® U.S. Materials Sector

ASYMMETRY® U.S. Consumer Staples Sector

ASYMMETRY® U.S. Consumer Discretionary Sector

ASYMMETRY® U.S. Energy Sector

ASYMMETRY® U.S. Industrials Sector

ASYMMETRY®, ASYMMETRY Investment Program®, ASYMMETRY Capital Partners®, and Global Tactical Rotation® are registered service marks of Shell Capital Management, LLC

 

Sector and Concentration Risks

Concentration Risk. To the extent the investment strategy invests more heavily in particular industries, groups of industries, or sectors of the economy, its performance will be especially sensitive to developments that significantly affect those industries, groups of industries, or sectors of the economy. Consumer Discretionary Sector Risk. The success of consumer product manufacturers and retailers is tied closely to the performance of domestic and international economies, interest rates, exchange rates, competition, consumer confidence, changes in demographics, and consumer preferences. Companies in the consumer discretionary sector depend heavily on disposable household income and consumer spending and may be strongly affected by social trends and marketing campaigns. These companies may be subject to severe competition, which may have an adverse impact on their profitability.

Health Care Sector Risk. Companies in the healthcare sector are subject to extensive government regulation, and their profitability can be significantly affected by restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure (including price discounting), limited product lines, and an increased emphasis on the delivery of healthcare through outpatient services. Companies in the healthcare sector are heavily dependent on obtaining and defending patents, which may be time-consuming and costly, and the expiration of patents may also adversely affect the profitability of these companies. Healthcare companies are also subject to extensive litigation based on product liability and similar claims. In addition, their products can become obsolete due to industry innovation, changes in technologies, or other market developments. Many new products in the healthcare sector require significant research and development and may be subject to regulatory approvals, all of which may be time-consuming and costly with no guarantee that any product will come to market.

Information Technology Sector Risk. Market or economic factors impacting information technology companies and companies that rely heavily on technological advances could have a significant effect on the value of the investment strategies’ investments. The value of stocks of information technology companies and companies that rely heavily on technology is particularly vulnerable to rapid changes in technology product cycles, rapid product obsolescence, government regulation, and competition, both domestically and internationally, including competition from foreign competitors with lower production costs. Stocks of information technology companies and companies that rely heavily on technology, especially those of smaller, less-seasoned companies, tend to be more volatile than the overall market. Information technology companies are heavily dependent on patent and intellectual property rights, the loss or impairment of which may adversely affect profitability. Additionally, companies in the technology sector may face dramatic and often unpredictable changes in growth rates and competition for the services of qualified personnel.